LNAI

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Lunai Bioworks Inc.

NASDAQ | LNAI

1.18

USD

$0.00

(

0.00%

)

At Close (As of Nov 28, 2025)

-

Market Cap

-

P/E Ratio

-

EPS

$21.00

52 Week High

$0.81

52 Week Low

HEALTHCARE

Sector

LNAI Chart

Recent Chart
Price Action

LNAI Technicals

Tags:

LNAI Earnings

Yearly Income Statement (As of Jun 30, 2025)

Field Value (USD)
Gross Profit -$129K
Total Revenue $0
Cost Of Revenue $129K
Costof Goods And Services Sold $129K
Operating Income -$189M
Selling General And Administrative $18M
Research And Development $537K
Operating Expenses $189M
Investment Income Net -
Net Interest Income -$609K
Interest Income $116K
Interest Expense $726K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $129K
Income Before Tax -$178M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$178M
Comprehensive Income Net Of Tax -
Ebit -$177M
Ebitda -$177M
Net Income -$178M

Revenue & Profitability

Earnings Performance

LNAI Financials

yearly Balance Sheet (As of Jun 30, 2025)

Field Value (USD)
Total Assets $8.2M
Total Current Assets $1M
Cash And Cash Equivalents At Carrying Value $93K
Cash And Short Term Investments $93K
Inventory -
Current Net Receivables -
Total Non Current Assets $7.2M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $166K
Intangible Assets Excluding Goodwill $166K
Goodwill $6M
Investments -
Long Term Investments -
Short Term Investments $388K
Other Current Assets $566K
Other Non Current Assets -
Total Liabilities $30M
Total Current Liabilities $29M
Current Accounts Payable $13M
Deferred Revenue -
Current Debt -
Short Term Debt $9.7M
Total Non Current Liabilities $425K
Capital Lease Obligations $738K
Long Term Debt -
Current Long Term Debt $9.4M
Long Term Debt Noncurrent -
Short Long Term Debt Total $10M
Other Current Liabilities $6.9M
Other Non Current Liabilities -
Total Shareholder Equity -$21M
Treasury Stock -
Retained Earnings -$510M
Common Stock $18K
Common Stock Shares Outstanding $17M

yearly Cash Flow (As of Jun 30, 2025)

Field Value (USD)
Operating Cashflow -$7.9M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $129K
Capital Expenditures $3
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$500K
Cashflow From Financing $8.4M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$178M

yearly Income Statement (As of Jun 30, 2025)

Field Value (USD)
Gross Profit -$129K
Total Revenue $0
Cost Of Revenue $129K
Costof Goods And Services Sold $129K
Operating Income -$189M
Selling General And Administrative $18M
Research And Development $537K
Operating Expenses $189M
Investment Income Net -
Net Interest Income -$609K
Interest Income $116K
Interest Expense $726K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $129K
Income Before Tax -$178M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$178M
Comprehensive Income Net Of Tax -
Ebit -$177M
Ebitda -$177M
Net Income -$178M

LNAI News

LNAI Profile

Lunai Bioworks Inc. Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Lunai Bioworks Inc. is a pre-clinical stage biotechnology firm based in Los Angeles, California, focusing on developing innovative medicines, diagnostics, and biodefense solutions for both the United States and international markets, particularly in the Netherlands. With a strong emphasis on cutting-edge research and development, Lunai Bioworks aims to address critical health challenges through its advanced biotechnological platforms and partnerships. The company is positioned to leverage its scientific expertise and strategic collaborations to drive meaningful advancements in the life sciences sector.

LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
VINE
+10.76%
$0.39
KTTA
+32.06%
$1.39
BITF
+11.91%
$3.10
IPG
-1.95%
$24.57
AXDX
-61.36%
$0.03
SPRC
-9.01%
$2.22
ADAP
-15.14%
$0.05
YGMZ
-8.37%
$0.11
AMD
+3.93%
$214.24
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
TLRY
-19.39%
$0.83
SRM
+53.27%
$10.30
BIYA
+11.34%
$0.28
BYND
+2.00%
$1.04
TWOH
0.00%
$0.00
RUBI
-24.69%
$0.16
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
AEHL
+8.43%
$3.47
ITUB
+3.23%
$7.66
NVDA
-1.02%
$178.41
AFMD
-34.94%
$0.18
INTC
+5.13%
$38.70
APLD
+5.05%
$24.94
CLSK
+13.34%
$15.24
SNAP
+0.23%
$7.62
ADTX
+27.38%
$4.00
INHD
-6.51%
$0.21
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
KWM
+10.50%
$0.72
KSS
+7.49%
$24.10
NAKA
+7.20%
$0.49
KDLY
+7.20%
$0.49
ASST
+2.65%
$1.16
SAND
-6.04%
$12.12
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
NBIS
+6.53%
$94.69
CIFR
+6.60%
$20.41
BMNR
+6.77%
$33.89
CHR
0.00%
$0.04
NEHC
+8.33%
$5.07
PLUG
+1.01%
$2.00
NIO
+0.72%
$5.49
IREN
-0.30%
$48.30
DEFT
+20.86%
$1.68
ONDS
-3.80%
$7.92
MPW
+2.12%
$5.77
WULF
+5.49%
$15.65
WFC
+0.54%
$85.56
GOOGL
-0.33%
$318.88
MARA
+6.50%
$11.83
GPUS
+1.14%
$0.33
TSLA
+0.65%
$429.38
IBRX
+2.40%
$2.13
CCCS
+0.96%
$7.32
FL
-0.37%
$24.01
DAL
+3.41%
$64.27
CPRT
-0.79%
$38.75
FI
+0.06%
$60.80
AG
+8.35%
$14.63
VGFC
-1.90%
$0.05
NEM
+5.21%
$90.52
WU
+0.58%
$8.67
SMX
+85.51%
$32.28
CRCA
+19.42%
$4.39
CRCL
+7.47%
$78.07
NUVB
+1.64%
$8.01
UAA
+2.66%
$4.62
SVMH
-14.58%
$0.73
AGL
+3.94%
$0.66
SPGC
-8.21%
$0.16
CX
+1.43%
$10.57
TMC
+11.40%
$6.49
BMNU
+9.30%
$8.21
SGHC
-6.74%
$10.93
TGI
+0.61%
$26.01
FNGB
+2.90%
$21.28
VSA
-5.29%
$0.11
ABVE
+4.21%
$2.74
BURU
+5.26%
$0.23
FRO
-1.95%
$23.52
SOFI
+1.64%
$28.96
F
+0.50%
$13.25
CRCG
+15.10%
$2.70
ZI
+0.51%
$9.67
TRVI
+16.98%
$13.29
DE
-5.67%
$469.87
NVTS
+8.33%
$9.03
ETHE
+3.36%
$24.86
BTG
+2.57%
$4.58
MAT
+2.31%
$21.24
DVLT
+0.47%
$2.14
AZI
+4.59%
$0.06
LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
VINE
+10.76%
$0.39
KTTA
+32.06%
$1.39
BITF
+11.91%
$3.10
IPG
-1.95%
$24.57
AXDX
-61.36%
$0.03
SPRC
-9.01%
$2.22
ADAP
-15.14%
$0.05
YGMZ
-8.37%
$0.11
AMD
+3.93%
$214.24
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
TLRY
-19.39%
$0.83
SRM
+53.27%
$10.30
BIYA
+11.34%
$0.28
BYND
+2.00%
$1.04
TWOH
0.00%
$0.00
RUBI
-24.69%
$0.16
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
AEHL
+8.43%
$3.47
ITUB
+3.23%
$7.66
NVDA
-1.02%
$178.41
AFMD
-34.94%
$0.18
INTC
+5.13%
$38.70
APLD
+5.05%
$24.94
CLSK
+13.34%
$15.24
SNAP
+0.23%
$7.62
ADTX
+27.38%
$4.00
INHD
-6.51%
$0.21
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
KWM
+10.50%
$0.72
KSS
+7.49%
$24.10
NAKA
+7.20%
$0.49
KDLY
+7.20%
$0.49
ASST
+2.65%
$1.16
SAND
-6.04%
$12.12
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
NBIS
+6.53%
$94.69
CIFR
+6.60%
$20.41
BMNR
+6.77%
$33.89
CHR
0.00%
$0.04
NEHC
+8.33%
$5.07
PLUG
+1.01%
$2.00
NIO
+0.72%
$5.49
IREN
-0.30%
$48.30
DEFT
+20.86%
$1.68
ONDS
-3.80%
$7.92
MPW
+2.12%
$5.77
WULF
+5.49%
$15.65
WFC
+0.54%
$85.56
GOOGL
-0.33%
$318.88
MARA
+6.50%
$11.83
GPUS
+1.14%
$0.33
TSLA
+0.65%
$429.38
IBRX
+2.40%
$2.13
CCCS
+0.96%
$7.32
FL
-0.37%
$24.01
DAL
+3.41%
$64.27
CPRT
-0.79%
$38.75
FI
+0.06%
$60.80
AG
+8.35%
$14.63
VGFC
-1.90%
$0.05
NEM
+5.21%
$90.52
WU
+0.58%
$8.67
SMX
+85.51%
$32.28
CRCA
+19.42%
$4.39
CRCL
+7.47%
$78.07
NUVB
+1.64%
$8.01
UAA
+2.66%
$4.62
SVMH
-14.58%
$0.73
AGL
+3.94%
$0.66
SPGC
-8.21%
$0.16
CX
+1.43%
$10.57
TMC
+11.40%
$6.49
BMNU
+9.30%
$8.21
SGHC
-6.74%
$10.93
TGI
+0.61%
$26.01
FNGB
+2.90%
$21.28
VSA
-5.29%
$0.11
ABVE
+4.21%
$2.74
BURU
+5.26%
$0.23
FRO
-1.95%
$23.52
SOFI
+1.64%
$28.96
F
+0.50%
$13.25
CRCG
+15.10%
$2.70
ZI
+0.51%
$9.67
TRVI
+16.98%
$13.29
DE
-5.67%
$469.87
NVTS
+8.33%
$9.03
ETHE
+3.36%
$24.86
BTG
+2.57%
$4.58
MAT
+2.31%
$21.24
DVLT
+0.47%
$2.14
AZI
+4.59%
$0.06
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.